Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,845,724
  • Shares Outstanding, K 145,941
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,792 M
  • EBITDA $ 2,028 M
  • 60-Month Beta 0.88
  • Price/Sales 7.12
  • Price/Cash Flow 22.40
  • Price/Book 5.98

Options Overview Details

View History
  • Implied Volatility 34.01% (+1.44%)
  • Historical Volatility 19.36%
  • IV Percentile 73%
  • IV Rank 37.60%
  • IV High 56.66% on 04/08/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 6) 7.28 (2.89%)
  • Put/Call Vol Ratio 2.11
  • Today's Volume 109
  • Volume Avg (30-Day) 197
  • Put/Call OI Ratio 2.83
  • Today's Open Interest 19,310
  • Open Int (30-Day) 21,382
  • Expected Range 245.19 to 259.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.68
  • Number of Estimates 6
  • High Estimate 2.74
  • Low Estimate 2.63
  • Prior Year 2.43
  • Growth Rate Est. (year over year) +10.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
240.00 +5.20%
on 01/02/26
259.99 -2.89%
on 12/10/25
+5.95 (+2.41%)
since 12/09/25
3-Month
237.63 +6.25%
on 12/01/25
277.85 -9.13%
on 10/10/25
-25.41 (-9.14%)
since 10/09/25
52-Week
199.92 +26.29%
on 04/07/25
293.81 -14.07%
on 08/22/25
+16.30 (+6.90%)
since 01/08/25

Most Recent Stories

More News
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday,...

RMD.AX : 37.300 (+0.54%)
RMD : 252.47 (+0.62%)
What You Need to Know Ahead of ResMed's Earnings Release

ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.

XLV : 157.31 (-0.51%)
$SPX : 6,966.28 (+0.65%)
RMD : 252.47 (+0.62%)
1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

RMD : 252.47 (+0.62%)
WDAY : 207.18 (-1.24%)
SAM : 207.82 (-0.69%)
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

WDFC : 190.00 (-6.63%)
RMD : 252.47 (+0.62%)
CR : 202.56 (+1.76%)
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present...

RMD.AX : 37.300 (+0.54%)
RMD : 252.47 (+0.62%)
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

INSP : 98.38 (+3.56%)
RMD : 252.47 (+0.62%)
SGRY : 16.12 (+2.61%)
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received...

RMD.AX : 37.300 (+0.54%)
RMD : 252.47 (+0.62%)
Is ResMed Stock Underperforming the S&P 500?

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,966.28 (+0.65%)
RMD : 252.47 (+0.62%)
ISRG : 586.24 (+0.20%)
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

RMD : 252.47 (+0.62%)
NEOG : 9.62 (-0.93%)
CBSH : 53.85 (-2.11%)
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

CORT : 37.50 (+2.66%)
ELAN : 23.47 (+0.99%)
LMAT : 85.00 (-0.05%)
PEN : 322.44 (+2.19%)
RMD : 252.47 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 257.76
2nd Resistance Point 255.78
1st Resistance Point 254.13
Last Price 252.47
1st Support Level 250.50
2nd Support Level 248.52
3rd Support Level 246.87

See More

52-Week High 293.81
Fibonacci 61.8% 257.94
Last Price 252.47
Fibonacci 50% 246.86
Fibonacci 38.2% 235.79
52-Week Low 199.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar